134 related articles for article (PubMed ID: 38761870)
1. Towards a greater understanding of the deep eutectic phenomenon through examination of the lidocaine-NSAID therapeutic deep eutectic systems.
Li S; Abdelquader MM; Andrews GP; Jones DS
Eur J Pharm Biopharm; 2024 Jul; 200():114329. PubMed ID: 38761870
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic deep eutectic solvents: A comprehensive review of their thermodynamics, microstructure and drug delivery applications.
Abdelquader MM; Li S; Andrews GP; Jones DS
Eur J Pharm Biopharm; 2023 May; 186():85-104. PubMed ID: 36907368
[TBL] [Abstract][Full Text] [Related]
3. Eutectic solutions for healing: a comprehensive review on therapeutic deep eutectic solvents (TheDES).
Kalantri S; Vora A
Drug Dev Ind Pharm; 2024 May; 50(5):387-400. PubMed ID: 38634708
[TBL] [Abstract][Full Text] [Related]
4. Selecting Excipients Forming Therapeutic Deep Eutectic Systems-A Mechanistic Approach.
Wolbert F; Brandenbusch C; Sadowski G
Mol Pharm; 2019 Jul; 16(7):3091-3099. PubMed ID: 31095911
[TBL] [Abstract][Full Text] [Related]
5. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies.
Duarte AR; Ferreira AS; Barreiros S; Cabrita E; Reis RL; Paiva A
Eur J Pharm Biopharm; 2017 May; 114():296-304. PubMed ID: 28189620
[TBL] [Abstract][Full Text] [Related]
6. Development of Polycaprolactone-Based metronidazole matrices for intravaginal extended drug delivery using a mechanochemically prepared therapeutic deep eutectic system.
Li S; Culkin A; Jones DS; Andrews GP
Int J Pharm; 2021 Jan; 593():120071. PubMed ID: 33246048
[TBL] [Abstract][Full Text] [Related]
7. Investigation on drug solubility enhancement using deep eutectic solvents and their derivatives.
Li Z; Lee PI
Int J Pharm; 2016 May; 505(1-2):283-8. PubMed ID: 27079143
[TBL] [Abstract][Full Text] [Related]
8. Design of arginine-based therapeutic deep eutectic solvents as drug solubilization vehicles for active pharmaceutical ingredients.
Gutiérrez A; Aparicio S; Atilhan M
Phys Chem Chem Phys; 2019 May; 21(20):10621-10634. PubMed ID: 31080981
[TBL] [Abstract][Full Text] [Related]
9. Design of controlled release systems for THEDES-Therapeutic deep eutectic solvents, using supercritical fluid technology.
Aroso IM; Craveiro R; Rocha Â; Dionísio M; Barreiros S; Reis RL; Paiva A; Duarte AR
Int J Pharm; 2015 Aug; 492(1-2):73-9. PubMed ID: 26142248
[TBL] [Abstract][Full Text] [Related]
10. Harnessing therapeutic deep eutectic solvents in self-emulsifying systems to improve CBD delivery.
Balenzano G; Racaniello GF; Spennacchio A; Lopalco A; Iacobazzi RM; Lopedota AA; Laquintana V; Denora N
Int J Pharm; 2024 Jun; 659():124267. PubMed ID: 38797251
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery.
Javed S; Mangla B; Sultan MH; Almoshari Y; Sivadasan D; Alqahtani SS; Madkhali OA; Ahsan W
Heliyon; 2024 May; 10(9):e29783. PubMed ID: 38694051
[TBL] [Abstract][Full Text] [Related]
12. Revealing Intermolecular Hydrogen Bonding Structure and Dynamics in a Deep Eutectic Pharmaceutical by Magic-Angle Spinning NMR Spectroscopy.
Mann SK; Pham TN; McQueen LL; Lewandowski JR; Brown SP
Mol Pharm; 2020 Feb; 17(2):622-631. PubMed ID: 31887061
[TBL] [Abstract][Full Text] [Related]
13. Optimal Design of THEDES Based on Perillyl Alcohol and Ibuprofen.
Silva E; Oliveira F; Silva JM; Matias A; Reis RL; Duarte ARC
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33233659
[TBL] [Abstract][Full Text] [Related]
14. Selective terpene based therapeutic deep eutectic systems against colorectal cancer.
Pereira J; Miguel Castro M; Santos F; Rita Jesus A; Paiva A; Oliveira F; Duarte ARC
Eur J Pharm Biopharm; 2022 Jun; 175():13-26. PubMed ID: 35483600
[TBL] [Abstract][Full Text] [Related]
15. Impact of the Dicarboxylic Acid Chain Length on Intermolecular Interactions with Lidocaine.
Zotova J; Twamley B; Tajber L
Mol Pharm; 2022 Aug; 19(8):2980-2991. PubMed ID: 35850530
[TBL] [Abstract][Full Text] [Related]
16. Ionic liquid formation with deep eutectic forces at an atypical ratio (2:1) of naproxen to lidocaine in the solid-state, thermal characterization and FTIR investigation.
Fiandaca M; Dalwadi G; Wigent R; Gupta P
Int J Pharm; 2020 Feb; 575():118946. PubMed ID: 31837407
[TBL] [Abstract][Full Text] [Related]
17. Characterization and comparison of lidocaine-tetracaine and lidocaine-camphor eutectic mixtures based on their crystallization and hydrogen-bonding abilities.
Gala U; Chuong MC; Varanasi R; Chauhan H
AAPS PharmSciTech; 2015 Jun; 16(3):528-36. PubMed ID: 25370024
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Role of Deep Eutectic Solvents Based on Menthol and Saturated Fatty Acids on Wound Healing.
Silva JM; Pereira CV; Mano F; Silva E; Castro VIB; Sá-Nogueira I; Reis RL; Paiva A; Matias AA; Duarte ARC
ACS Appl Bio Mater; 2019 Oct; 2(10):4346-4355. PubMed ID: 32030369
[TBL] [Abstract][Full Text] [Related]
19. The effect of electrostatic interactions on the formation of pharmaceutical eutectics.
Wojnarowska Z; Smolka W; Zotova J; Knapik-Kowalczuk J; Sherif A; Tajber L; Paluch M
Phys Chem Chem Phys; 2018 Nov; 20(43):27361-27367. PubMed ID: 30357184
[TBL] [Abstract][Full Text] [Related]
20. Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents.
Pereira CV; Silva JM; Rodrigues L; Reis RL; Paiva A; Duarte ARC; Matias A
Sci Rep; 2019 Oct; 9(1):14926. PubMed ID: 31624310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
